Skip to main content
Premium Trial:

Request an Annual Quote

Veritas Genetics Establishing Asian R&D Center

NEW YORK (GenomeWeb) – Veritas Genetics said today it is creating an R&D center in China to develop genetic products targeting the Asian population. 

The new center will be headquartered in Hangzhou and led by Managing Director Jonathan Zhao; Vice President of Global Clinical and Regulatory Affairs Lei Li; and Vice President of China R&D Min Wang. 

Veritas, which is based in Boston, said that with the new center it is carrying out its mission to "make disease prevention through genetic screening products accessible globally." 

The China center will develop products that address "the unique variants which are common in Asian populations," Li said in a statement. Veritas noted as an example alpha thalassemia, an inherited blood disorder for which as much as 14 percent of populations in parts of Asia carry disease variants. 

Veritas was founded in 2014 and recently launched a BRCA1 and BRCA2 test for $199. The test, called myBRCA, for hereditary ovarian and breast cancer received CE marking last month.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.